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Introduction 
On April 8, 2010, the Robert Wood Johnson Foundation (RWJF) convened a 
payment reform advisory panel composed of health policy experts as well as 
representatives of health plans, purchasers, consumer groups, health 
professionals, government and philanthropy. Please see the attached participant 
list. The panel developed a set of general, high level recommendations to the 
field of relevant policymakers and health care stakeholders regarding pragmatic 
next steps necessary for payment reforms. Reforming payment is a critical piece 
of the ongoing, years-long effort to help American health care drive sustainable 
high quality, efficient, and high value care. Most understand that current 
payment strategies too often promote fragmentation and high volume rather 
than high value. The recent Patient Protection and Affordable Care Act (PPACA) 
incorporates this view about the critical nature of payment reform for the 
overall success of health care reform. The advisory panel made its 
recommendations against this reform backdrop of heightened attention to and 
concern about the success of payment reform.  
This paper provides a brief summary of the key issues raised by the panel’s 
discussion and some next step recommendations. It reviews the observations 
made by the panelists on the key issues stakeholders will face in a post-reform 
world. It then concludes with recommendations for achieving successful 
reforms. 
Summary of Key Points  
The panel identified several issues that should remain top of mind for 
stakeholders: 
Goal. It is very important to keep the goals in mind—payment reform is 
not an end in and of itself—rather we are urgently seeking payment 
reforms to support and drive sustainable high value care. Also, payment 
and incentives are critical and necessary for high value care—they are 
not, however, sufficient. 
Community. While improving health care is a national priority, health 
care is organized and delivered at a community level. Health care, itself, 
is an intensely local matter. Further, health care payment is, at its core, a 
transactional activity between or among interested parties paying for 
and providing services. Nevertheless, successful payment reform 
depends on more than national impetus and local transactional activity. 
The ability of each community and its local health care stakeholders to 
design and implement payment reforms will be critical to the success of 
those reforms. Payment reform is both a national issue, because of 
national payers such as Medicare, and a local issue, because negotiations 
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at the local level reflect local market conditions. At a minimum, 
successful payment reform requires participation and collaboration of 
key stakeholders in local communities as well as conducive, supportive 
national leadership.  Payment reform requires action at both the 
national and local levels. 
Information. Payment reform cannot be successful without appropriate 
information to support it. For example, although a growing number of 
useful measures exist, payment reforms that will drive high value will 
require substantially more and better information about the quality and 
cost of care. Those developing and implementing payment experiments 
need better process and quality measures, better and more outcome 
measures, consumer and patient-centered results oriented measures, 
cost and efficiency measures, and value measures. National 
measurement entities should accelerate efforts to develop and 
implement this wide range of measurement. Making that information 
public and transparent should also be a high priority. Some panelists 
noted that a completely revised system of measurement is needed to 
guide fundamental payment reforms, not simply more measures. 
Nevertheless, the critical nature of payment reform dictates that the field 
cannot wait on the perfect metrics or measurement system before 
developing viable payment models. The ongoing development of 
measures and payment models will need to unfold concurrently. 
Measures that will support payment reforms also need accessible, 
available, accurate and timely data. All relevant parties should make 
concerted efforts to ensure that measurement efforts have the necessary 
accurate, timely data. Here too, though, payment reforms cannot wait for 
the perfect—most believe that there is sufficient data right now to 
proceed. 
Consumer. Payment reform will not be successful if it does not support 
care changes that consumers see as improvements. High value care is 
care that is of value to the health care consumer—if consumers don’t 
value it, it’s not high value. The field cannot achieve high value care 
without orienting the underlying measures, outcomes and payment tools 
to the consumer perspective. Also, the task of incorporating the 
consumer perspective is not an after the fact messaging challenge, but 
rather, a concerted, explicit effort to bring the consumer concerns and 
desires into every stage of the payment reform process. However, 
messaging does matter. Not only do measures, outcomes and tools need 
to reflect the consumer perspective, but there is also a significant 
communications and messaging challenge when engaging the public 
about reducing costs. 
Coordination. Reorienting payment away from incentives for 
fragmentation and high volume to alignment and high value is one of the 
most complex parts of an overall health care reform. It is fraught with 
risk for failure. It requires dramatically more coordination than any part 
of health care is currently accustomed to providing. For example, the 
multiple payers in each community need to develop coordinated 
payment reforms so that providers have consistent incentives and are 
not overburdened with the administrative tasks involved with multiple 
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payment systems. The various new and existing relevant federal 
agencies responsible for delivery and payment reform must prioritize, 
network and communicate with each other and align their various 
reform efforts and strategies all to ensure that learning is disseminated 
quickly, gaps are addressed systematically, progress is sustained, and 
needless redundancy is avoided. Local community leaders must work 
together to resolve political tensions in their local markets in order to 
facilitate local payment experimentation and reforms. The non-profit 
sector should communicate with other funders and prioritize their 
disparate efforts to promote payment experimentation maximally. And 
the field of interested policy makers and stakeholders needs to knit 
together the various pieces of reform into a cohesive plan that integrates 
other reforms, like health IT implementation and comparative 
effectiveness research, into the effort.  
Commercial Plans and Medicaid. Payment experiments must engage 
both Medicare and commercial plans if they are to be successful. One of 
the biggest problems with current payment experimentation around the 
country is getting commercial plans, particularly national plans, to 
support locally-defined payment and delivery reforms. Attention to 
Medicaid is also critical. Medicaid is already a large purchaser of health 
care—and will likely have an even larger set of responsibilities as PPACA 
reforms unfold. Payment reform must explicitly incorporate state and 
federal Medicaid perspectives into the models and strategies. 
Setting the Initial Mile Posts: Key Issues In the Post-
Reform World 
While the health reform debate and enactment of PPACA have enhanced 
momentum for payment reform, many questions remain unanswered.  
The Centers for Medicare and Medicaid Services (CMS) will be responsible for 
executing the demonstrations, pilots, and other programs called for in the law, 
but there is uncertainty about what tasks lie ahead for stakeholders who want to 
participate, as well as how these reforms will play out through private sector 
initiatives. The advisory panel highlighted several key issues or principles for 
moving forward:   
Community. Successful reform will require participation and 
collaboration of key stakeholders in local communities – working 
together to implement innovative payment schemes that promote 
quality improvement and cost containment. Without the support of all 
relevant stakeholders in a given locale, reform initiatives may not 
achieve the desired goal of high value care.   
Measurement and Data. Reforming payment so that it rewards high 
value health care means that the ability to measure the quality processes 
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and outcomes, as well as the cost, efficiency and value of care are 
critically important. Similarly, timely access to data needed to redesign 
payment systems and care delivery systems is critically important.  
Existing performance measures need to be updated and expanded to 
capture relevant information for a multitude of purposes and 
stakeholders; however, perfection must not be the enemy of good. 
Stakeholders should not wait for perfect measures to implement reforms 
– they’ll be waiting forever.  
Coordination. In addition to payment reform, there are a number of 
other separate initiatives already underway or just beginning, including 
incentives for adoption of electronic health records, investment in 
comparative effectiveness research, and development of a national 
quality measurement strategy. These initiatives can vastly accelerate, 
and be enhanced by, payment reform. It is essential to recognize that 
these initiatives – along with payment reform – are all components of a 
larger reform movement—and to create a conceptual understanding of 
how all these pieces fit together to drive sustainable high value care. 
Consumers. Reform efforts that are not informed by consumers’ 
perspectives are not likely to achieve the desired perspective of high 
value care for consumers.  That point is particularly true if consumers 
feel they will lose flexibility or autonomy in where and from whom they 
seek care. In addition to payment changes, consumer benefit design 
must be adjusted to improve the alignment of consumer and payment 
incentives. 
Commercial plans. Payment experiments must engage both Medicare 
and commercial plans if they are to be successful. One of the biggest 
problems with current payment experimentation around the country is 
getting commercial plans, particularly national plans, to support locally-
defined payment and delivery reforms. 
Medicaid. Similarly, state Medicaid programs should be at the table. In 
the near future, Medicaid will be the largest payer for health care 
services in the country. As such, state Medicaid programs’ participation 
and support will be necessary for reforms to be successful.  
Illuminating the Pathway: Recommendations for the 
Field 
Based on these themes or principles, the payment reform advisory group 
identified key tasks for stakeholders and recommendations on roles and 
responsibilities as we move down the path to reform.  
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There are a number of stakeholders who need to be involved in executing these 
tasks – not only those who will be directly impacted by payment reform, such as 
providers, payers, patients, consumers and purchasers, but also those whose 
support will be essential to success, like local and regional coalitions, the HIT 
and measurement communities, academics and other thought leaders, and non-
profits such as philanthropies. 
Most of the tasks will require collective action, while others will fall on one or 
only a few stakeholders. Where appropriate, we have noted which stakeholders 
should be responsible for taking the lead roles.  
1. Identify opportunities for quality improvement and cost savings.  
Different types of payment reforms can and should be used to solve 
different problems – payment reform is not a “one size fits all” strategy. 
For example, a bundled payment approach can help to reduce variation 
in costs of episodes of care, while a global payment can be used to 
reduce the frequency and volume of certain episodes. Stakeholders, 
including purchasers, payers, providers, and coalitions need to examine 
the opportunities to improve quality and reduce costs in their 
communities to identify which payment reforms might be best suited to 
meet their needs. By identifying explicit objectives, the payment reform 
can be much more targeted and, presumably, more successful.  
2. Craft short and long-term strategies. 
Some payment reforms are more incremental in nature; others will 
require significant changes in claims processing, benefit design, delivery 
system organization and ultimately professional, patient and consumer 
behavior and will thus take longer to design and implement. 
Stakeholders should consider short-term strategies, such as making 
incremental reforms to the fee-for-service system, while working to 
refine longer-term approaches, like bundled payments for acute or 
chronic care episodes.  
Extracting greater value from the fee-for-service system is critical, as 
more complex payment models often use those payment levels as a 
foundation for setting episode-based and global payment levels. 
Stakeholders in the research community (e.g., academics and non-profits 
such as foundations) should help to define the appropriate future uses of 
fee-for-service to take advantage of its inherent incentive to drive 
volume over value, such as payments for preventive care or 
immunizations.  
Longer-term strategies should also include recommendations for 
aligning multiple reform efforts, such as comparative effectiveness 
research and health information technology adoption, to fully support 
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6 
transformation of payment and delivery structures. Non-profits such as 
philanthropies seem well positioned to lead the charge in disseminating 
the learning about best practices for such alignment. They may also have 
a role in promoting the development and evaluation of those practices.  
3. Identify potential unintended consequences and possible remedies. 
Payment reform could render multiple benefits to the health care 
system, but it is equally important to recognize the potential unintended 
consequences of overhauling long-standing payment and delivery 
models. For instance, in anticipation of pending payment reforms, some 
stakeholders might perceive incentives to pay close attention to key 
baseline measures such as status quo cost—and then to increase those 
pre-reform baselines to maximize the opportunity to achieve “savings”. 
That maneuver could have the unintended effect of promoting health 
care inflationary pressures rather than efficiencies and value—at least in 
the near term. 
Using the accountable care organization as another example, one of the 
primary hoped-for benefits of this model is that it will promote clinical 
integration and provider collaboration to make care more cost-effective. 
While integration is often deemed a positive result of reform, there is the 
potential for integration to lead to significant market consolidation – 
integration to the point of creating monopolies – which could actually 
lead to anticompetitive pricing behaviors that drive prices and costs up.  
Another example of a potential unintended consequence pertains to 
global payments and capitation. In those payment methods, providers 
receive a set amount for treating a population of patients. If providers’ 
spending exceeds this set amount, they are not eligible to receive 
additional reimbursement. Providers, therefore, have a strong incentive 
to keep costs under the budgeted amount. Without proper protections, 
like risk-adjustment or quality metrics, providers may under-treat or 
refuse to treat patients likely to need costly services for fear that they 
will overspend.  
Communities seeking to understand the impact of local payment reforms 
need to have a clear understanding of these and other potential 
unintended consequences, as well as actionable strategies they can put 
in place to avoid the possible pitfalls. A number of stakeholders should 
be involved in articulating the range of unintended consequences 
associated with various payment reforms – including health plans, 
academics and other thought leaders, and non-profits such as 
philanthropies. The federal government (and regional, state or local 
government entities) should leverage their power as conveners to bring 
relevant stakeholders such as – providers, patients, consumers and 
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payers – together to agree on how they will monitor and minimize the 
impact of unintended consequences.  
4. Create tools for success. 
Once stakeholders have identified their priorities and are oriented to the 
road that lies ahead, they will need tools and technical assistance to 
assist them with implementations. It is not enough simply to create 
financial incentives that would reward providers for high-quality, cost-
effective care. Without tools to help build the skills and capacity 
necessary to achieve those objectives, payment reforms are not likely to 
improve quality and reduce costs. 
The leading payment reform concepts assume a certain level of 
coordination, collaboration, and practice redesign to reduce 
inappropriate utilization of services across the spectrum of care. An 
example of this assumption is a payment model that financially rewards 
physicians for reducing avoidable hospitalizations for complications 
related to chronic conditions. Under the current payment schemes, it has 
not generally been necessary for physicians to develop the capacity for 
care management in order to maximize payment – and, in fact, in the fee 
for service status quo adding this capacity would likely perversely 
penalize physicians with higher cost and no compensating revenue. 
Consequently, physicians will likely need help to develop case 
management and other types of improvement capacity and capability. 
The task of creating and disseminating these tools must be a shared 
responsibility. Stakeholders like academics and thought leaders, non-
profits such as philanthropies, and local or regional alliances should take 
a leading role in assessing the improvement needs of providers and 
making recommendations for tactical steps to achieve higher-quality, 
cost effective care. Health plans should use their experience with 
utilization management to help providers identify opportunities for 
efficiency and quality gains, while the HIT community might work to 
build clinical decision support tools to deploy evidence-based guidelines 
to providers at the point of care.   
5. Measure and report on progress.  
Measurement is central to understanding the impact of payment 
reforms. There are two distinct categories of measurement necessary for 
payment reform. The first is measuring the quality, cost, efficiency and 
value of care. Payment reforms that reward high value require 
information about quality and cost in order to work. The second is 
measuring whether implemented payment reforms actually work in 
enabling and encouraging high value care.  
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8 
For the first category – measuring quality and cost of care – obviously, 
many measures exist; however, these metrics largely examine structures 
and processes of care. Outcomes measures are particularly challenging 
to construct and validate. They are even more challenging to develop 
across episodes of care that span multiple providers and care settings. 
The field also needs significantly more and better measures for cost and 
efficiency of care. Stakeholders agree that existing measures need to be 
improved and expanded to encompass the range of stakeholders and 
uses of the information to truly understand the impact of payment 
reforms. Additionally, stakeholders agree that measures can and should 
be used to increase the level of accountability for providers. The need for 
measures of accountability is particularly true under models like global 
payments, which may create incentives for providers to under-treat 
patients who need higher (and often more expensive) amounts of care – 
further exacerbating disparities for minority and low-income 
populations. Some panelists strongly argued that the problem was not 
simply more measures—that more measures would never be sufficient 
to understand impacts of incentives and interventions on total costs. 
These panelists argued that a completely revised system of 
measurement is needed to guide fundamental payment reforms, not 
simply more measures. The difficult but necessary tasks of updating and 
expanding measures should fall primarily to those developing and 
endorsing measures, but again, all measures should be informed by the 
full complement of stakeholders, including consumers.  
The second category, assessing and measuring the impact of reform, will 
be challenging. First, a broad range of stakeholders need to reach 
consensus on a consistent nomenclature for the types of reforms. For 
example, currently, bundled payments and episode-of-care payments 
are often used interchangeably, and stakeholders may have differing 
understandings of the scope of services included in each – if in fact they 
are distinct reforms.  Second, stakeholders probably need to reach 
agreement on a “scorecard” that could be used to measure and compare 
different payment approaches.  Again, these tasks might fall to 
academics and thought leaders and philanthropies as leaders and 
conveners of a broad range of stakeholders, including providers, payers, 
purchasers, and patients. Formal assessment and evaluation is probably 
critical to assessing the success and viability of various kinds of payment 
efforts. 
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Conclusion  
PPACA will shift the health care delivery and payment landscape dramatically; 
however, considerable challenges around implementation of payment reforms 
must be resolved to reach the desired outcomes of improved quality and 
reduced costs. The considerations and recommendations raised by the advisory 
panel should help guide public and private stakeholders as they begin to explore 
how to apply innovative health care payment concepts in their communities.   
Leaders in both the public and private sectors need to tackle these issues now, 
not only to ensure that providers are able to meet the demand of 
transformation, but also to guarantee long-term success of the vision for a high-
value health care system.  
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Appendix 
Pinpointing the Destination: Payment Reform Elements in Health Reform  
A primary goal of health care reform is to contain rising health care costs by 
realigning financial incentives for providers to supply high-quality care in a cost-
effective manner. Over the past twenty years, Congress has continuously sought 
to find potential solutions by enacting demonstration programs in Medicare and 
Medicaid. Through PPACA, Congress took an important step toward supporting 
locally-defined innovations in care delivery and payment models.  
PPACA includes a number of care delivery and payment reform provisions. The 
law directs the Secretary of Health and Human Services (HHS) to establish a 
Medicare Shared Saving (i.e., accountable care organizations, or ACO) program, 
in which groups of providers that form ACOs will be allowed to share in savings 
achieved through higher quality and more efficient care provided to Medicare 
patients. The program will test multiple payment approaches, including a risk 
sharing model. PPACA also includes a one-year Pediatric ACO demonstration for 
Medicaid based on a shared savings model. Both the Medicare and Medicaid 
programs are slated to begin in January 2012.  
The new health reform law promotes the patient-centered medical home 
(PCMH) model. A medical home provides accessible, continuous, 
comprehensive, and coordinated care. The law permits the Secretary to award 
grants to states to implement multidisciplinary “health teams” to support the 
PCMH. Health team requirements include the use of certified electronic health 
records and implementation of interdisciplinary care plans that integrate 
clinical and community prevention and health promotion services for patients.  
PPACA includes two bundled payment demonstrations. The first is a Medicaid 
bundled payment demonstration that would pay for hospital and physician 
services for an episode-of-care surrounding a hospitalization. The 
demonstration would begin in 2012 and be conducted in up to 8 states. The 
second is a Medicare pilot program for bundling payments for acute, post-acute 
care, and ambulatory services. The pilot will be for ten conditions selected by 
the Secretary and will begin by 2013. In addition to the bundled payment 
demonstration, PPACA also extends the current Medicare Hospital Gainsharing 
Demonstration until September 30, 2011. The Gainsharing Demonstration tests 
financial arrangements between hospitals and physicians under a shared 
savings model. The savings are a result of collaborative efforts between the 
hospital and the physician to improve overall care quality and efficiency.  
Congress also established the Center for Medicare and Medicaid Innovation, 
within the Centers for Medicare & Medicaid Services (CMS), which starting in 
January 2011 will begin testing innovative care delivery and payment models 
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for Medicare and Medicaid beneficiaries. PPACA also creates an Independent 
Payment Advisory Board which starting in 2014 will submit proposals to 
Congress on how to reduce Medicare spending while preserving and enhancing 
care quality. 
Lastly, PPACA established a hospital value-based purchasing (VBP) program and 
a hospital readmissions program which will begin in 2013 as well as a value 
based physician payment program which will start in 2011. These VBP efforts 
will allow for payment differentials to physicians or physicians groups based on 
quality and provide incentive payments to hospitals that meet certain quality 
benchmarks while the readmission program would reduce payment to hospitals 
for preventable readmissions. 
While these reforms lead toward the possibility of greater value in health care, 
the law includes little detailed guidance on how to get there. The aim of the 
payment reform advisory panel and RWJF is to help fill in some of these gaps for 
stakeholders.  
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